The field of regulated cell death has undergone a transformative shift with the discovery of novel modalities beyond apoptosis, such as ferroptosis, which ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

Metastasis and disease progression remain the leading causes of mortality in both breast and cervical cancer. These processes ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

Researchers find that pancreatic cancer cell signals reprogrammed macrophages to suppress immune response and fuel tumor ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

A new publication from CorriXR Therapeutics, an oncology focused biotherapeutics company developing genetic medicines to ...

Janux Therapeutics has partnered with Bristol Myers Squibb in a global licensing and collaboration deal to advance a ...

A U.S.-based clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company conducts ...